Table 4.
Intergroup differences regarding MA and MOA.
| Projects | Groups | Intra-group differences | Intergroup differences | |||
|---|---|---|---|---|---|---|
| M0 | M12 | p-Value | M12 Project change | p-Value | ||
| VAS | MA | 7.64 ± 0.97 | 1.51 ± 2.27 | <0.05 | −1.68 ± 0.62 | 0.009 |
| MOA | 7.61 ± 0.67 | 3.19 ± 2.97 | <0.05 | |||
| HIT-6 | MA | 66.58 ± 4.58 | 41.24 ± 8.60 | <0.05 | −7.63 ± 2.56 | 0.005 |
| MOA | 67.58 ± 5.18 | 48.87 ± 12.73 | <0.05 | |||
| PedMIDAS | MA | 49.76 ± 7.64 | 4.44 ± 9.82 | <0.05 | −11.56 ± 3.86 | 0.005 |
| MOA | 49.68 ± 7.42 | 16.00 ± 20.21 | <0.05 | |||
| Migraine burden | MA | 89.21 ± 45.42 | 5.69 ± 16.05 | <0.05 | −27.15 ± 9.07 | 0.005 |
| MOA | 96.58 ± 43.48 | 32.84 ± 49.06 | <0.05 | |||
VAS, Visual Analogue Scale; HIT-6, Headache Impact Test; PedMIDAS, Pediatric Migraine Disability Assessment; MA, migraine with aura; MOA, migraine without aura; M0, Baseline; M12, at 12 months postoperative; PFO, patent foramen ovale.